Canada markets open in 6 hours 5 minutes

Kiromic BioPharma, Inc. (KRBP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.2300+0.1300 (+4.19%)
At close: 02:32PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
10,572
9,625
13,920
11,368
5,053
-
Selling General and Administrative
9,703
10,314
17,194
13,938
14,144
-
Total Operating Expenses
20,275
19,939
31,114
25,306
19,197
-
Operating Income or Loss
-20,275
-19,939
-31,114
-25,306
-19,197
-
Interest Expense
2,479
1,852
166.5
12.2
3.3
-
Total Other Income/Expenses Net
-
842.2
-3,450
-270.8
-
-
Income Before Tax
-21,797
-20,949
-34,731
-25,589
-19,200
-
Income Tax Expense
-
-
-
-
-
0
Income from Continuing Operations
-21,797
-20,949
-34,731
-25,589
-19,200
-
Net Income
-21,797
-20,949
-34,731
-25,589
-19,200
-
Net Income available to common shareholders
-25,237
-23,499
-35,076
-25,811
-19,913
-
Basic EPS
-19.51
-12.59
-64.42
-67.81
-132.60
-
Diluted EPS
-19.51
-12.59
-64.42
-67.81
-132.60
-
Basic Average Shares
932.02
1,098
544.475
380.607
150.195
-
Diluted Average Shares
932.02
1,098
544.475
380.607
150.195
-